A Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic Asthma

NCT01285323 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

464

Enrollment

INDUSTRY

Sponsor class

Conditions

Eosinophilic Asthma

Interventions

DRUG: Reslizumab
DRUG: Placebo

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.